Loading…
InMode Ltd. is projected to rise to $20.36 by 2027, a +33% move from its current price of $15.28. INMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $15.05 | $15.29 | $15.53 | +0.06% |
| Jul 14 | $14.96 | $15.30 | $15.64 | +0.11% |
| Jul 15 | $14.89 | $15.31 | $15.73 | +0.17% |
| Jul 16 | $14.84 | $15.31 | $15.80 | +0.22% |
| Jul 17 | $14.79 | $15.32 | $15.87 | +0.28% |
| Jul 18 | $14.75 | $15.33 | $15.93 | +0.33% |
| Jul 19 | $14.71 | $15.34 | $15.99 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.71 | $15.34 | $15.99 | +0.39% |
| Week 2 | $14.52 | $15.40 | $16.33 | +0.77% |
| Week 3 | $14.38 | $15.46 | $16.61 | +1.16% |
| Week 4 | $14.28 | $15.52 | $16.87 | +1.55% |
| Week 5 | $14.19 | $15.58 | $17.10 | +1.95% |
| Week 6 | $14.12 | $15.64 | $17.32 | +2.34% |
| Week 7 | $14.06 | $15.70 | $17.53 | +2.73% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedures.
The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation.
The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd.
in November 2017. The company was incorporated in 2008 and is headquartered in Yokne’am, Israel. Healthcare.
InMode Ltd. (INMD) is a healthcare company with a current price of $14.79 and a market capitalization of $850.14M. It holds a rank of 2658 by market cap.
The stock’s near-term outlook is reflected in a neutral sentiment today, with a 30-day trading range of $13.14 to $16.65 and a current price at the upper end of that range. The forecast trajectory shows potential upside over the coming years, culminating in a multi-year rise from a 2026 average of $14.79 to higher long-term levels.
Forecasts project gradual upward movement, with 2027 average $19.22, 2028 $21.87, 2029 $25.56, and 2030 $26.56 on average. Max values rise to $36.23 by 2030, $91.28 by 2040, and $202.41 by 2050, with corresponding ROI% figures of 30, 47.9, 72.8, 79.6, and beyond. The outlook becomes strongly bullish by the end of the forecast horizon, though these are estimates and not guarantees.
A major floor 18.1% below — a decisive break under it would weaken the trend.
The nearest floor, 13.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 9.0% above — clearing it would confirm fresh momentum.
Key INMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.78 | Buy | $14.90 | Buy |
| MA 10 | $14.74 | Buy | $14.69 | Buy |
| MA 20 | $14.21 | Buy | $14.40 | Buy |
| MA 50 | $14.01 | Buy | $14.13 | Buy |
| MA 100 | $13.94 | Buy | $14.12 | Buy |
| MA 200 | $14.35 | Buy | $14.40 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 69.74 | Neutral |
| Stoch RSI (14) | 98.20 | Sell |
| CCI (20) | 111.18 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 14.46 | Buy |
| Bollinger %B (20,2) | 0.89 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.23 | Buy |
| Awesome (5,34) | 0.79 | Buy |
| Ultimate (7,14,28) | 73.66 | Sell |
| Momentum (10) | 0.47 | Buy |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 14.88 | Buy |
| ADX (14) | 23.88 | Buy |
| ATR (14) | 0.19 | Info |
The 30-day technical picture is mixed but leans toward neutrality. RSI14 sits at 70, with the near-term price trading around the 50-day moving average at $13.93 and the 200-day moving average at $14.36.
Support is cited at $13.21 and resistance at $14.79, with a 30-day price range of $13.14 to $16.65. The current price of $14.79 sits at the resistance level, and overall sentiment is NEUTRAL. Annualized volatility is about 30%, indicating a relatively active trading range over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $12.76 | $15.28 | $20.62 | 0% | Neutral | |
| $16.67 | $20.36 | $25.99 | +33% | Bullish | |
| $18.88 | $23.48 | $30.79 | +54% | Bullish | |
| $21.44 | $27.09 | $36.27 | +77% | Bullish | |
| $22.72 | $29.08 | $39.64 | +90% | Bullish | |
| $23.67 | $30.68 | $42.48 | +101% | Bullish | |
| $25.00 | $32.76 | $46.01 | +114% | Bullish | |
| $28.40 | $37.61 | $53.50 | +146% | Bullish | |
| $34.27 | $45.84 | $65.99 | +200% | Bullish | |
| $36.51 | $49.29 | $71.75 | +223% | Bullish | |
| $49.46 | $69.65 | $106.25 | +356% | Bullish | |
| $96.36 | $145.53 | $237.96 | +852% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $12.76 | $15.28 | $18.01 | +0.00% |
| August 2026 | $13.11 | $15.35 | $18.36 | +0.46% |
| September 2026 | $13.66 | $16.07 | $19.37 | +4.67% |
| October 2026 | $14.03 | $16.57 | $20.10 | +3.13% |
| November 2026 | $13.95 | $16.54 | $20.17 | -0.20% |
| December 2026 | $14.15 | $16.82 | $20.62 | +1.71% |
Click any year to see its month-by-month INMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
InMode Ltd.'s 2026 outlook centres on $15.28, within a $12.76 to $20.62 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, INMD could reach as high as $25.99, with a base case around $20.36 and support toward $16.67 — roughly +33% from $15.28. Momentum favours further upside here.
Expect INMD to range from $18.88 to $30.79 through 2028. The $23.48 average target implies a +54% move from current prices. That is up +15% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The INMD price prediction for 2029 points to an average of $27.09 (low $21.44, high $36.27) — a potential gain of +77% on today's $15.28. Momentum favours further upside here.
In 2030, INMD is projected to trade between $22.72 and $39.64, averaging $29.08 — a potential gain of +90% from today's $15.28. That is up +7% on the projected 2029 average. Buyers look set to stay in control over this stretch.
InMode Ltd.'s 2031 outlook centres on $30.68, within a $23.67 to $42.48 range. That is up +5% on the projected 2030 average. That marks a +101% change versus current levels. Momentum favours further upside here.
By 2032, INMD could reach as high as $46.01, with a base case around $32.76 and support toward $25.00 — roughly +114% from $15.28. Buyers look set to stay in control over this stretch.
Expect INMD to range from $28.40 to $53.50 through 2033. The $37.61 average target implies a +146% move from current prices. That is up +15% on the projected 2032 average. Momentum favours further upside here.
The INMD price prediction for 2034 points to an average of $45.84 (low $34.27, high $65.99) — a potential gain of +200% on today's $15.28. Buyers look set to stay in control over this stretch.
In 2035, INMD is projected to trade between $36.51 and $71.75, averaging $49.29 — a potential gain of +223% from today's $15.28. That is up +8% on the projected 2034 average. Momentum favours further upside here.
InMode Ltd.'s 2040 outlook centres on $69.65, within a $49.46 to $106.25 range. That is up +41% on the projected 2035 average. That marks a +356% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, INMD could reach as high as $237.96, with a base case around $145.53 and support toward $96.36 — roughly +852% from $15.28. Momentum favours further upside here.
Investing $1,000 in INMD today (≈ 65.445026 INMD) could be worth
$9,524.38
+$8,524.38 (+852%) by 2050 · US Dollar
Based on the average projected INMD price of $145.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INMDwould be worth at today's price.
$1,000 invested in INMD on Jul 10, 2025 (≈ 65.876152 INMD) would be worth
$1,006.59
+$6.59 (+0.7%) today · 1.01× · US Dollar
Based on a INMD entry price of $15.18 vs. today's $15.28.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.8 | $1,032.43 | +3.2% |
| 1 month ago | $13.47 | $1,134.37 | +13.4% |
| 3 months ago | $13.53 | $1,129.34 | +12.9% |
| 6 months ago | $14.49 | $1,054.52 | +5.5% |
| 1 year ago | $15.18 | $1,006.59 | +0.7% |
| All time (5.0y) ago | $54.39 | $280.93 | -71.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INMD forecast.
Our base-case forecast reaches $31.00 around 2032.
Implied market cap at $31.00: $1.78B
Looking out across the multi-year forecast, INMD shows a bullish trajectory with rising averages and positive ROI across the horizon. The 2027 average is $19.22 (ROI 30) and the 2028 average is $21.87 (ROI 47.9), followed by 2029 at $25.56 (ROI 72.8) and 2030 at $26.56 (ROI 79.6).
The forecast strengthens further into 2031–2035, with 2031 averaging $27.48 (ROI 85.8), 2032 $30.06 (ROI 103.2), and 2033 $33.43 (ROI 126.1). By 2034 the average reaches $40.23 (ROI 172) and by 2035 $43.96 (ROI 197.2). In the longer term, the 2040 average is $59.82 (ROI 304.4) and the 2050 average is $123.76 (ROI 736.8).
These figures depict a rising price path with bullish sentiment across the forecast horizon, but they are estimates, not guarantees. Investors should recognize that outcomes can vary and that future performance may differ from these projections.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $26.56 with ROI 79.6 and a bullish sentiment.
Forecasts from 2027 onward are listed as BULLISH, with 2027 avg $19.22 (ROI 30), 2028 $21.87 (ROI 47.9), 2029 $25.56 (ROI 72.8), and 2030 $26.56 (ROI 79.6). The 2026 forecast is neutral with an average of $14.79 and ROI 0.
Yes, the max forecast by 2050 is $202.41, with the 2050 average of $123.76, indicating potential to exceed $100 under the projected path.
The 30-day range is $13.14 to $16.65; RSI14 is 70; SMA50 is $13.93; SMA200 is $14.36. Current price is $14.79 with support at $13.21 and resistance at $14.79; sentiment NEUTRAL and annualized volatility 30%.
Current price is $14.79; market cap is $850.14M; rank is 2658; sentiment is NEUTRAL; 30% annualized volatility.
InMode Ltd. Community Discussion
0Share your InMode Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.